Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

174 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The optimal MMF dose in tacrolimus treated patients.
van Gelder T, Bouamar R, Shuker N, Hesselink D, Weimar W, Kaplan B, Bernasconi C. van Gelder T, et al. Am J Transplant. 2014 May;14(5):1221. doi: 10.1111/ajt.12682. Epub 2014 Mar 17. Am J Transplant. 2014. PMID: 24636529 No abstract available.
Acute kidney injury following left ventricular assist device implantation: Contemporary insights and future perspectives.
Yalcin YC, Bunge JJH, Guven G, Muslem R, Szymanski M, den Uil CA, Hesselink DA, Topkara VK, Manintveld OC, Colombo PC, Bogers AJJC, Caliskan K. Yalcin YC, et al. J Heart Lung Transplant. 2019 Aug;38(8):797-805. doi: 10.1016/j.healun.2019.06.001. Epub 2019 Jun 19. J Heart Lung Transplant. 2019. PMID: 31352996
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.
Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. Pascual J, et al. Transplant Rev (Orlando). 2019 Oct;33(4):191-199. doi: 10.1016/j.trre.2019.07.001. Epub 2019 Jul 23. Transplant Rev (Orlando). 2019. PMID: 31377099 Review.
A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement.
Andrews LM, de Winter BCM, Cornelissen EAM, de Jong H, Hesselink DA, Schreuder MF, Br├╝ggemann RJM, van Gelder T, Cransberg K. Andrews LM, et al. Clin Pharmacokinet. 2020 May;59(5):591-603. doi: 10.1007/s40262-019-00831-8. Clin Pharmacokinet. 2020. PMID: 31654367 Free PMC article.
Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients.
Mendoza Rojas A, Hesselink DA, van Besouw NM, Baan CC, van Gelder T. Mendoza Rojas A, et al. Expert Rev Clin Immunol. 2019 Dec;15(12):1323-1331. doi: 10.1080/1744666X.2020.1693263. Epub 2019 Nov 27. Expert Rev Clin Immunol. 2019. PMID: 31721605
Costimulation Blockade in Kidney Transplant Recipients.
van der Zwan M, Hesselink DA, van den Hoogen MWF, Baan CC. van der Zwan M, et al. Among authors: Hesselink DA. Drugs. 2020 Jan;80(1):33-46. doi: 10.1007/s40265-019-01226-6. Drugs. 2020. PMID: 31749062 Free PMC article. Review.
Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal Multicenter Study.
Yalcin YC, Muslem R, Veen KM, Soliman OI, Hesselink DA, Constantinescu AA, Brugts JJ, Manintveld OC, Fudim M, Russell SD, Tomashitis B, Houston BA, Hsu S, Tedford RJ, Bogers AJJC, Caliskan K. Yalcin YC, et al. Among authors: Hesselink DA. J Card Fail. 2020 Apr;26(4):333-341. doi: 10.1016/j.cardfail.2020.01.010. Epub 2020 Jan 23. J Card Fail. 2020. PMID: 31981698 Free article.
Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival.
Roest S, Hesselink DA, Klimczak-Tomaniak D, Kardys I, Caliskan K, Brugts JJ, Maat APWM, Ciszek M, Constantinescu AA, Manintveld OC. Roest S, et al. Among authors: Hesselink DA. ESC Heart Fail. 2020 Apr;7(2):533-541. doi: 10.1002/ehf2.12585. Epub 2020 Feb 5. ESC Heart Fail. 2020. PMID: 32022443 Free PMC article.
174 results
Jump to page